Evidence map›Paper›PMID 42303611›Full record

ArticleNature communications2026

Disease-associated genetic variants can cause missense effects in tissue-specific protein isoforms.

Giovanna Weykopf, Mihaly Badonyi, Elias T Friman, Jasmine Minh Hang Nguyen, Alexis Ioannou, Benjamin J Livesey, Audrey Coutts, Elizabeth F Hird, Murray Wham, Chloe M Stanton and 8 more

Abstract read
In one paragraph

Article in Nature communications, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed.

  1. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

18 authors.

Giovanna WeykopfMRC Human Genetics Unit, Institute of Genetics and Cancer, University of Edinburgh, Edinburgh, UK.
Mihaly Badonyi *MRC Human Genetics Unit, Institute of Genetics and Cancer, University of Edinburgh, Edinburgh, UK.
Elias T Friman *MRC Human Genetics Unit, Institute of Genetics and Cancer, University of Edinburgh, Edinburgh, UK.
Jasmine Minh Hang Nguyen *Liver Enzymes in Metabolism and Inflammation, Centenary Institute, Sydney, NSW, Australia.
Alexis IoannouMRC Human Genetics Unit, Institute of Genetics and Cancer, University of Edinburgh, Edinburgh, UK.
Benjamin J LiveseyMRC Human Genetics Unit, Institute of Genetics and Cancer, University of Edinburgh, Edinburgh, UK.
Audrey CouttsClinical Research Facility Genetics Core, University of Edinburgh, Edinburgh, UK.
Elizabeth F HirdNHS Lothian, Edinburgh, UK.
Murray WhamBioinformatics analysis core, Institute of Genetics and Cancer, University of Edinburgh, Edinburgh, UK.
Chloe M StantonMRC Human Genetics Unit, Institute of Genetics and Cancer, University of Edinburgh, Edinburgh, UK.ORCID http://orcid.org/0000-0003-1248-1916
Veronique VitartMRC Human Genetics Unit, Institute of Genetics and Cancer, University of Edinburgh, Edinburgh, UK.
Jing SuBioinformatics analysis core, Institute of Genetics and Cancer, University of Edinburgh, Edinburgh, UK.
Lee MurphyClinical Research Facility Genetics Core, University of Edinburgh, Edinburgh, UK.ORCID http://orcid.org/0000-0001-6467-7449
J Kenneth BaillieMRC Human Genetics Unit, Institute of Genetics and Cancer, University of Edinburgh, Edinburgh, UK.ORCID http://orcid.org/0000-0001-5258-793X
Mark D GorrellLiver Enzymes in Metabolism and Inflammation, Centenary Institute, Sydney, NSW, Australia.ORCID http://orcid.org/0000-0002-0528-2604
Joseph A MarshMRC Human Genetics Unit, Institute of Genetics and Cancer, University of Edinburgh, Edinburgh, UK. Joseph.Marsh@ed.ac.uk.ORCID http://orcid.org/0000-0003-4132-0628
Wendy A BickmoreMRC Human Genetics Unit, Institute of Genetics and Cancer, University of Edinburgh, Edinburgh, UK. Wendy.Bickmore@ed.ac.uk.
Simon C BiddieMRC Human Genetics Unit, Institute of Genetics and Cancer, University of Edinburgh, Edinburgh, UK. Simon.Biddie@ed.ac.uk.ORCID http://orcid.org/0000-0002-8253-0253

Funding

Chief Scientist Office (CSO) PCL/20//02EC | Horizon 2020 Framework Programme (EU Framework Programme for Research and Innovation H2020) 101001169RCUK | MRC | Medical Research Foundation MC_UU_00035/7RCUK | MRC | Medical Research Foundation MC_UU_00035/9Wellcome TrustWellcome Trust (Wellcome) 223164/Z/21/Z
6 · The paper itself

Abstract

Genetic variants can cause protein-coding mutations that result in disease. Variants are typically interpreted using the reference transcript for a gene. However, most human multi-exon genes have alternative isoforms. We show that, consistent with their reduced evolutionary constraint, coding exons in alternative isoforms harbour more population variants than exons of reference isoforms, and that these variants are more likely to cause nonsynonymous mutations. Common and rare disease-associated variants mapping to alternative transcripts can lead to amino acid substitutions predicted to be structurally damaging in the corresponding protein isoform. The alternative transcripts to which disease-associated variants map demonstrate high tissue-specificity, with many unannotated in reference human genomes, and only revealed by long-read RNA-sequencing. As an example, we report an unannotated, alternative transcript of the inflammasome regulator DPP9 that is lung epithelium-specific, that harbours a common genetic variant associated with severe COVID-19 and lung fibrosis. Using deep RNA sequencing of full-length transcript isoforms by targeted capture, we confirm the expression of the unannotated DPP9 isoform. The DPP9 isoform variant causes a p.Leu8Pro missense mutation in an alternative first exon, predicted to disrupt the encoded alpha helix, and we show that the variant alters DPP9 enzymatic activity. Our findings highlight the importance of considering alternative isoforms, their tissue-specific expression, and full-length transcripts in variant interpretation, with implications for uncovering underappreciated mechanisms of both common and rare disease.

Indexed as

Genetic VariationMutation, MissenseAlternative SplicingExonsHumansLungOrgan SpecificityProtein IsoformsSARS-CoV-2Protein Isoforms

Identifiers

PMID42303611
PMCPMC13429693

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.